Terrestrial Bio

PharmaceuticalsSeries CWoburn, USterrestrialbio.com

Latest round

Series C

Last raised

Mar 2026

Total raised

$124M

Investors

7

About Terrestrial Bio

Founded in 2012 by Kathryn Kosuda (CSO) and Livio Valenti, and based in Massachusetts, US, Vaxess Technologies, Inc. is a life science company that develops technologies based on a silk biopolymer platform for the delivery of vaccines and therapeutics.  In March 2026, Terrestrial Bio, Inc.  Vaxess Technologies Inc. is developing advanced delivery systems for vaccines and therapeutics using its MIMIX™ platform, which employs silk fibroin biomaterials. This technology enables needle-free, refrigeration-free administration, allowing self-administration at home or in low-resource settings. The MIMIX™ patch uses a microarray of bioactive tips to gradually release medications after application.

Who invested in Terrestrial Bio

7 investors across 6 rounds

See all investors in Terrestrial Bio

Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.

Funding rounds

  1. Series C

    Mar 26, 2026

    Amount

    $50M

    Investors

    Locked

  2. Series B

    Jul 17, 2023

    Amount

    $9.1M

    Investors

    Locked

  3. Series B

    Apr 29, 2021

    Amount

    $25M

    Investors

    Locked

  4. Series B

    Apr 29, 2021

    Amount

    $35M

    Investors

    Locked

  5. Series A

    Jun 27, 2019

    Amount

    $3.6M

    Investors

    Locked

  6. Series A

    May 29, 2013

    Amount

    $1.3M

    Investors

    Locked

Questions about Terrestrial Bio

Who invested in Terrestrial Bio?

Terrestrial Bio has 7 investors on record across 6 venture rounds. Sign up free to see every VC on the cap table and the rounds they joined.

How much funding has Terrestrial Bio raised?

Terrestrial Bio has raised 6 venture rounds. Sign up free to see how much each round raised and the total.

When did Terrestrial Bio last raise money?

Terrestrial Bio's most recent round on record is a Series C, in Mar 2026.

What does Terrestrial Bio do?

Founded in 2012 by Kathryn Kosuda (CSO) and Livio Valenti, and based in Massachusetts, US, Vaxess Technologies, Inc.

Where is Terrestrial Bio headquartered?

Terrestrial Bio is headquartered in Woburn, US.

Which VCs invest in companies like Terrestrial Bio?

Among active investors with capital left to deploy, Andreessen Horowitz, Founders Fund, Accel and Thrive Capital back pharmaceuticals companies at Terrestrial Bio's stage. Their profiles are linked below.

Raising like Terrestrial Bio? Find the right VCs.

Capital Atlas matches your startup to active investors by stage, sector and region.

Free to start. Upgrade when you're ready to reach out.